Senti Biosciences Inc.

NASDAQ:SNTI 3:46:53 PM EDT

0.30

+0.02 (+6.80%)

7:40:59 PM EDT: $0.30 0.00 (-0.33%)

Market Cap (Intraday)	13.73M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.62 Million
Adjusted EPS	-$0.42

See more estimates

10-Day MA	$0.31
50-Day MA	$0.39
200-Day MA	$0.49

See more pivots

Senti Biosciences Inc. Stock, NASDAQ:SNTI

2 Corporate Drive, First Floor, South San Francisco, California 94080

United States of America

Phone: +1.650.239.2030

Number of Employees: 48

http://www.sentibio.com

Description

Senti Biosciences, Inc. is a biotechnology company. It engages in the business of developing next-generation cell and gene therapies engineered with a gene circuit platform technology to fight challenging diseases. The company was founded by Timothy K. Lu, Wilson Wong, and Philip Lee on June 9, 2016 and is headquartered in South San Francisco, CA.